Holds one active US DMF and one valid CEP for labetalol, filing since 1995. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds one active US DMF and one valid CEP for labetalol, filing since 2002. Its 2023 FDA inspection closed as VAI.
Holds 2 active US DMFs for labetalol, filing since 1997. Its 2022 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for labetalol, filing since 2000. Its 2022 FDA inspection closed as VAI.
Holds one active US DMF for labetalol, filing since 1994. Its 2022 FDA inspection closed as VAI.
This page filters the worldwide Labetalol manufacturer list to companies based in Italy. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free